Skip to main content
OpenTrials

Clinical trial condition

Heart Diseases

Explore clinical trials studying Heart Diseases. Study availability and eligibility vary by location and protocol.

18,202 public trials 3,081 recruiting studies
Refine in advanced search Browse all conditions

Heart Diseases trial results

Active, Not Recruiting

BIO|MASTER.CSP Study

NCT06620237

Conditions
Arrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, +10 more
Locations
  • Integral Healthcare Adelaide, Australia
  • Victorian Heart Hospital Clayton, Australia
  • Lyell McEwin Hospital Elizabeth Vale, Australia
  • AZ Sint-Jan Bruges, Belgium
View all 14 locations
View Trial Details
Active, Not Recruiting

NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population

NCT03613246

Conditions
Aortic Valve Disease, Aortic Valve Stenosis, Cardiovascular Diseases, +4 more
Locations
  • Oulu University Hospital Oulu, Finland
  • Herz- und Gefäßzentrum Bad Bevensen Bad Bevensen, Germany
  • Schuechtermann-klinik Bad Rothenfelde, Germany
  • Kath. Marienkrankenhaus Hamburg, Germany
View all 14 locations
View Trial Details
Active, Not Recruiting

ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

NCT03517436

Conditions
Aortic Valve Disease, Aortic Valve Stenosis, Cardiovascular Diseases, +3 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • UC Health Northern Colorado (Medical Center of the Rockies) Loveland, Colorado, United States
  • Washington Hospital Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Gene Therapy for ACM Due to a PKP2 Pathogenic Variant

NCT06109181

Conditions
Arrhythmogenic Cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, Cardiomyopathies, +14 more
Locations
  • Stanford University Stanford, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Rochester Rochester, New York, United States
View Trial Details
Active, Not Recruiting

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

NCT04475926

Conditions
Cardiomyopathies, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arkansas Children's Little Rock, Arkansas, United States
  • University of California San Diego La Jolla, California, United States
  • University of California, Davis Health Dept of PM&R Sacramento, California, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation

NCT04755283

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +10 more
Locations
  • Anthos Investigative Site Huntsville, Alabama, United States
  • Anthos Investigative Site Mobile, Alabama, United States
  • Anthos Investigative Site Stamford, Connecticut, United States
  • Anthos Investigative Site Clearwater, Florida, United States
View all 92 locations
View Trial Details
Active, Not Recruiting

PARTNER 3 Trial - Mitral Valve in Valve

NCT03193801

Conditions
Cardiovascular Diseases, Heart Diseases, Heart Failure, +4 more
Locations
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Northshore University Health System Research Institution Evanston, Illinois, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions